SwissChems
Affiliate WorldwideWorldwide vendor that publishes CoAs, but the lab is anonymous and certificates are not authenticable at the source.
Verified 9/10 of 10 criteria · checked 2026-07-09
Publishes CoAs, but the testing lab is unnamed and the certificates cannot be authenticated at the source (absent from Janoshik/Finnrick databases). The site sits behind Cloudflare (403 to bots), so it needs manual monitoring; most values are indirect, drawn from third-party audits. A 2024 FDA warning letter is worth noting.
Is SwissChems legit?
On PeptideTrust's 10-criterion transparency scorecard, SwissChems scores 47/100 with 90% evidence coverage. That measures how openly it documents third-party testing, not the quality or safety of any product.
Is SwissChems a scam?
We make no fraud claim either way — PeptideTrust scores documentary transparency, not criminality. SwissChems scores 47/100 with 90% evidence coverage, and the table below links to exactly what we could and couldn't verify. Thin transparency is a reason for caution, not proof of a scam; a high score is not a guarantee of product quality.
Does SwissChems do independent third-party testing?
That is exactly what our scorecard measures. SwissChems has 9 of 10 weighted criteria verified (90% coverage); each row in the table below links to the third-party certificate, the named lab and the date we checked. Read the evidence rather than trusting a badge.
Criterion-by-criterion evidence
Every score below is a recorded, dated observation. Where we could not verify a claim, the criterion is marked Unverified and excluded from the score (but it still counts against coverage).
| Criterion | Wt | Finding | Evidence |
|---|---|---|---|
| Publishes CoAsThe vendor publishes at least one certificate of analysis (CoA) on its own website. | 3 | ✔ Yes | The /independent-test-results/ page exists (403 = a real URL behind Cloudflare); third-party audits (vialaudit 78/100) confirm CoA PDFs. Not opened directly. Source · 2026-07-09 |
| Batch-level CoAsCoAs are tied to a specific batch/lot number, not a single generic certificate per product. | 3 | ◐ Partial | Batch IDs reported by audits (ED8349, CY09-C) but coverage judged inconsistent ("on request"). Third-party sourced, not verified live. Source · 2026-07-09 |
| Third-party lab namedThe name of the laboratory that ran the analysis appears on the CoA. | 2 | ✘ No | Lab not named publicly ("US-certified third-party laboratory", anonymous) per two audits. Source · 2026-07-09 |
| Independent / accredited labThe lab is independent of the vendor and/or accredited (ISO 17025), or is a recognised independent peptide lab (e.g. Janoshik, MZ Biolabs). | 2 | ? Unverified | Not verified — no evidence on record. |
| CoA verifiable at sourceThe CoA can be authenticated on the laboratory's own website (e.g. a verification code) — actually tested, not just claimed. | 2 | ✘ No | Absent from public Janoshik/Finnrick databases; only vendor-hosted PDFs, not authenticable at the lab. Source · 2026-07-09 |
| Identity + purity methodsWhich analytical methods are identifiable on the published CoAs. | 2 | ? Unverified HPLC only | "HPLC third-party" claimed; one audit adds LC-MS (conflicting). Conservative floor = HPLC. Not verified live. Source · 2026-07-09 |
| Freshness of the latest CoADate of the most recent CoA visible on the site. | 2 | ? Unverified < 3 months | Audit (vialaudit): most recent test April 2026. Indirect. Source · 2026-07-09 |
| CoAs accessible before purchase, no accountCoAs can be viewed without a customer account or a prior purchase. | 2 | ◐ Partial | A public page exists (no login) but per-product CoAs are "not systematically linked / on request" per audits. Source · 2026-07-09 |
| Sterility / endotoxin data publishedSterility or endotoxin (LAL) results are published in addition to purity. | 1 | ✘ No | No sterility/endotoxin data mentioned in the audits (purity only). Source · 2026-07-09 |
| Public complaints / recall handlingA public recall/complaint policy, or documented handling of a disputed batch. | 1 | ✘ No | No documented recall policy. Context: FDA Warning Letter MARCS-CMS 695663 (2024-12-10) on Semaglutide/Retatrutide. Source · 2026-07-09 |
Full scoring rubric on the methodology page. How affiliation is handled: read the disclosure.
Score history
- 2026-07-09 — Added to the scorecard after the initial CoA-transparency audit.